Duopharma Biotech Berhad announced re-designation of Dato' Eisah Binti A. Rahman from independent non-executive director to senior independent non-executive director. Date of change is 1 June 2023. Age: 67.

Qualifications: Diploma, Postgraduate Diploma in Medical Microbiology, Institute for Medical Research, Kuala Lumpur, Malaysia; Masters, Master of Science in Pharmaceutical Analysis, University of Manchester, United Kingdom; Degree, Bachelor's in Pharmacy, Curtin University of Technology, Western Australia. Working experience and occupation: Past Appointments/Experiences: Pharmacist, National Pharmaceutical Control Laboratory (NPCL) from 1979 to 1992; Head, Microbiology Laboratory, NPCL from 1992 to 1997; Head, GMP & Licensing, National Pharmaceutical Control Bureau (NPCB) from 1997 to 2001; Kelantan State Pharmacist, Ministry of Health Malaysia (MoH) from 2001 to 2002; Deputy Director, Product Evaluation & Safety Division, NPCB from 2002 to 2005; Secretary, Drug Control Authority (DCA), NPCB from 2002 to 2005; Member, Malaysian Advertisement Board (MAB), MoH from 2002 to 2006; Chairman, Malaysian Adverse Drug Reactions Advisory Committee (MADRAC) from 2005 to 2006; Director, NPCB now known as the National Pharmaceutical Regulatory Agency (NPRA) from 2005 to 2006; Director, Pharmacy Enforcement of Pharmaceutical Services Division, MoH from 2007 to 2008; Secretary, Malaysian Poison Board, MoH from 2007 to 2008; Senior Director, Pharmaceutical Services, MoH from 2008 to 2016; Alternate Chairman, DCA and MAB, MoH from 2008 to 2016; Registrar, Malaysian Pharmacy Board, MoH from 2008 to 2016; Member/Alternate Chairman, MoH Drug Formulary from 2005 to 2016; Chairman, ASEAN Consultative Committee for Standards & Quality (ACCSQ) Pharmaceutical Product Working Group (PPWG) from 2008 to 2016. Dato' Eisah Binti A. Rahman has been appointed as the Senior Independent Non-Executive Director with effect from 1 June 2023, in place of Dato' Mohamad Kamarudin Bin Hassan.

Dato' Mohamad Kamarudin has served as an Independent Non-Executive Director of the company for a cumulative period of nine (9) years and therefore retired on 31 May 2023 in accordance with the company's board charter that limits the tenure of Independent Non-Executive Directors and Non-Independent Non-Executive Directors to not more than nine (9) years.